Migra Therapeutics

Migra Therapeutics is an Emory University spinout developing receptor-targeted, stroma-penetrating hyaluronic acid nanoparticles to deliver chemotherapy and other payloads into drug-resistant solid tumors such as pancreatic and breast cancer.